Who Owns Oric Pharmaceuticals Stock?
NASDAQ: ORICHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 119.29%
- Institutions (% of float)
- 121.35%
- Held by insiders
- 1.69%
- Institutional holders
- 257
- Institutions 98.3%
- Insiders 1.7%
- Public and other 0.0%
Who owns Oric Pharmaceuticals stock?
Institutional investors own about 119.3% of Oric Pharmaceuticals's shares, spread across 257 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.69% of ORIC.
The largest institutional holders are Nextech Invest, Ltd. (6.91%), Blackrock Inc. (6.73%) and EcoR1 Capital, LLC (6.49%). Together, the top 10 institutions control 52.0% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their ORIC positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ORIC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Nextech Invest, Ltd. | 7.16M | 6.91% | 0.0% |
| Blackrock Inc. | 6.98M | 6.73% | +2.3% |
| EcoR1 Capital, LLC | 6.73M | 6.49% | 0.0% |
| Price (T.Rowe) Associates Inc | 6.62M | 6.38% | +22.8% |
| Viking Global Investors, L.P. | 5.13M | 4.95% | -12.0% |
| SR One Capital Management, LP | 4.62M | 4.45% | +2.2% |
| Venrock Adviser, LLC | 4.32M | 4.17% | 0.0% |
| State Street Corporation | 4.13M | 3.98% | -15.7% |
| NEA Management Company, LLC | 4.12M | 3.97% | 0.0% |
| Vanguard Capital Management LLC | 4.07M | 3.93% | +3.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ORIC
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.92M | 2.82% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.42M | 2.33% |
| iShares Trust-iShares Russell 2000 ETF | 1.94M | 1.87% |
| ACAP Strategic Fund | 1.85M | 1.79% |
| T. Rowe Price Health Sciences Fund, Inc. | 1.53M | 1.48% |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 1.26M | 1.22% |
| T. Rowe Price New Horizons Fund, Inc. | 1.11M | 1.08% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 951.43K | 0.92% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 942.75K | 0.91% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 818.61K | 0.79% |
Frequently asked questions
Who is the largest shareholder of Oric Pharmaceuticals?
Nextech Invest, Ltd. is the largest institutional shareholder of ORIC, owning 6.91% of shares outstanding (7.16M shares) as of its latest 13F filing.
What percentage of Oric Pharmaceuticals is owned by institutions?
Institutions own about 119.3% of ORIC shares and 121.3% of the public float.
How much of Oric Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 1.69% of ORIC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.